Screener
Pacific Biosciences of California PACB Asia-Pacific — Total Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
| (In thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Americas | $17,624 | $17,687 | $34,309 | $33,990 |
| Europe, Middle East and Africa | 14,426 | 9,467 | 25,195 | 18,707 |
| Asia-Pacific | 6,957 | 12,612 | 16,681 | 24,222 |
| Total revenue | $39,007 | $39,766 | $76,185 | $76,919 |
Item 1. Financial Statements (unaudited):
FAQ
- What is Pacific Biosciences of California's asia-pacific — total revenue?
- Pacific Biosciences of California (PACB) reported asia-pacific — total revenue of $6.96M in Q2 2026.
- How has Pacific Biosciences of California's asia-pacific — total revenue changed year-over-year?
- Pacific Biosciences of California's asia-pacific — total revenue decreased by 44.8% year-over-year, from $12.61M to $6.96M.
- What is the long-term trend for Pacific Biosciences of California's asia-pacific — total revenue?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's asia-pacific — total revenue has grown at a 4.8% compound annual growth rate (CAGR), from $35.72M to $43.16M.
- What does asia-pacific — total revenue mean?
- This metric represents the total gross revenue generated from the sale of genetic sequencing platforms, consumables, and related services within the Asia-Pacific geographic region. It serves as a key indicator of the company's market penetration, adoption rates of sequencing technology, and competitive positioning in this specific international market. Tracking this revenue stream helps investors assess the company's ability to scale its global footprint and capture demand in emerging biotechnology sectors across Asia.
Ask your AI about Pacific Biosciences of California's asia-pacific — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude